Abstract:Introduction: The intricate interplay between gut microbiota and hyperuricemia remains a subject of growing interest. However, existing studies only provided snapshots of the gut microbiome at single time points, the temporal dynamics of gut microbiota alterations during hyperuricemia progression and the intricate interplay between the gut barrier and microbiota remain underexplored. Our investigation revealed compelling insights into the dynamic changes in both gut microbiota and intestinal barrier function throughout the course of hyperuricemia. Methods: The hyperuricemia mice (HY) were given intragastric administration of adenine and potassium oxalate. Gut microbiota was analyzed by 16S rRNA sequencing at 3, 7, 14, and 21 days after the start of the modeling process. Intestinal permeability as well as LPS, TNF-α, and IL-1β levels were measured at 3, 7, 14, and 21 days. Results: We discovered that shifts in microbial community composition occur prior to the onset of hyperuricemia, key bacterial Bacteroidaceae, Bacteroides, and Blautia exhibited reduced levels, potentially fueling microbial dysbiosis as the disease progresses. During the course of hyperuricemia, the dynamic fluctuations in both uric acid levels and intestinal barrier function was accompanied with the depletion of key beneficial bacteria, including Prevotellaceae, Muribaculum, Parabacteroides, Akkermansia, and Bacteroides, and coincided with an increase in pathogenic bacteria such as Oscillibacter and Ruminiclostridium. This microbial community shift likely contributed to elevated lipopolysaccharide (LPS) and pro-inflammatory cytokine levels, ultimately promoting metabolic inflammation. The decline of Burkholderiaceae and Parasutterella was inversely related to uric acid levels, Conversely, key families Ruminococcaceae, Family_XIII, genera Anaeroplasma exhibited positive correlations with uric acid levels. Akkermansiaceae and Bacteroidaceae demonstrating negative correlations, while LPS-containing microbiota such as Desulfovibrio and Enterorhabdus exhibited positive correlations with intestinal permeability. Conclusion: In summary, this study offers a dynamic perspective on the complex interplay between gut microbiota, uric acid levels, and intestinal barrier function during hyperuricemia progression. Our study suggested that Ruminiclostridium, Bacteroides, Akkermansiaceae, Bilophila, Burkholderiaceae and Parasutterella were the key bacteria that play vital rols in the progress of hyperuricemia and compromised intestinal barrier, which provide a potential avenue for therapeutic interventions in hyperuricemia.

Alteration of Gut Microbiome and Correlated Amino Acid Metabolism Contribute to Hyperuricemia and Th17-Driven Inflammation in Uox-KO Mice

The gut microbiota as a target to control hyperuricemia pathogenesis: Potential mechanisms and therapeutic strategies

Association of Hyperuricemia With Immune Disorders and Intestinal Barrier Dysfunction

Alterations in the gut microbiome and metabolism profiles reveal the possible molecular mechanism of renal injury induced by hyperuricemia in a mouse model of renal insufficiency

A dynamics association study of gut barrier and microbiota in hyperuricemia

Hyperuricemia is Associated with Impaired Intestinal Permeability in Mice

Integrated Microbiome and Metabolome Analysis Reveals the Key Role of Taurohyocholate in the Treatment of Hyperuricemia with Lacticaseibacillus Rhamnosus 2016SWU.05.0601

Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout

Lactobacillus rhamnosus GG ameliorates hyperuricemia in a novel model

Association Between Gut Microbiota and Elevated Serum Urate in Two Independent Cohorts

Metagenomic analysis revealed the potential role of gut microbiome in gout

Altered Gut Microbiota in Children With Hyperuricemia

Metagenomic Study Revealed the Potential Role of the Gut Microbiome in Gout

Antibiotic-induced gut microbiota dysbiosis has a functional impact on purine metabolism

Deletion of the Uox gene generates a mouse model of hyperuricemia with cardiovascular complications

The altered gut microbiota of high-purine-induced hyperuricemia rats and its correlation with hyperuricemia

Causal Effects of Gut Microbiota on Gout and Hyperuricemia: Insights from Genome-Wide Mendelian Randomization, RNA-Sequencing, 16S rRNA Sequencing, and Metabolomes

Lactobacillus Plantarum LLY-606 Supplementation Ameliorates Hyperuricemia Via Modulating Intestinal Homeostasis and Relieving Inflammation.

Probiotic Therapy Alleviates Hyperuricemia in C57bl/6 Mouse Model

Hyperuricemia drives intestinal barrier dysfunction by regulating gut microbiota